Page last updated: 2024-08-24

3-iodobenzylguanidine and Neuroleptic Malignant Syndrome

3-iodobenzylguanidine has been researched along with Neuroleptic Malignant Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Isobe, M; Iwama, T; Kawabata, M; Kubo, I; Suzuki, K; Terai, T	1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Neuroleptic Malignant Syndrome

Article	Year
'Tako-Tsubo cardiomyopathy' associated with syndrome malin: reversible left ventricular dysfunction. Circulation journal : official journal of the Japanese Circulation Society, 2003, Volume: 67, Issue:8 Topics: 3-Iodobenzylguanidine; Aged; Amantadine; Antidepressive Agents, Tricyclic; Cardiomyopathies; Coronary Angiography; Humans; Imipramine; Male; Neuroleptic Malignant Syndrome; Radionuclide Imaging; Radiopharmaceuticals; Recovery of Function; Thallium Radioisotopes; Ventricular Dysfunction, Left	2003

Article

Year

'Tako-Tsubo cardiomyopathy' associated with syndrome malin: reversible left ventricular dysfunction.

Circulation journal : official journal of the Japanese Circulation Society, 2003, Volume: 67, Issue:8

Topics: 3-Iodobenzylguanidine; Aged; Amantadine; Antidepressive Agents, Tricyclic; Cardiomyopathies; Coronary Angiography; Humans; Imipramine; Male; Neuroleptic Malignant Syndrome; Radionuclide Imaging; Radiopharmaceuticals; Recovery of Function; Thallium Radioisotopes; Ventricular Dysfunction, Left

2003